Literature DB >> 8052709

[Long-term results after TIPSS with the Palmaz stent].

G M Richter1, T Roeren, M Brado, G Nöldge, G W Kauffmann.   

Abstract

Since our first clinically successful TIPSS procedure in 1988 numerous steps to improve the safety and methodology have helped to increase the technical and clinical success while the rate of complications could be significantly reduced. In our series of more than 200 patients the technical success rate is more than 95% and the early clinical success rate (< 30 days after TIPSS) 89%, respectively. Early shunt occlusion was found in 1.5% of our patients. 3 months after TIPSS, however, transjugular portography reveals significant shunt stenosis in 46% needing either shunt re-dilatation or additional stent placement. This relatively high rate of re-intervention is being significantly reduced during the further follow-up with a frequency of 17% at a 6 month interval and 6% at a 12 month interval, respectively. The need for re-intervention is strongly associated with liver function and the patients' coagulation status: Child's A patients needed re-intervention substantially more often than those in stage B or C at each given follow-up interval. The decreasing need for re-intervention over time appears to be associated with the formation of an endothelial cell layer on the surface of the shunt tract.

Entities:  

Mesh:

Year:  1994        PMID: 8052709

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  2 in total

1.  Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy.

Authors:  N Kochar; D Tripathi; H Ireland; D N Redhead; P C Hayes
Journal:  Gut       Date:  2006-03-29       Impact factor: 23.059

2.  Implantability, Complications, and Follow-Up After Transjugular Intrahepatic Portosystemic Stent-Shunt Creation With the 6F Self-Expanding Sinus-SuperFlex-Visual Stent.

Authors:  Daniel Spira; Jakub Wiskirchen; Ulrich Lauer; Dominik Ketelsen; Konstantin Nikolaou; Benjamin Wiesinger
Journal:  Iran J Radiol       Date:  2016-02-17       Impact factor: 0.212

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.